EUVIMEDEUVIMED entdecken
Crossref

Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody

Haiwei Cheng, Li Yang, Liting Hou, Zizheng Cai, Xiaoming Yu, Luping Du, Jin Chen, Qisheng Zheng

International Immunopharmacology · 2023

DOI: 10.1016/j.intimp.2023.110140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2023. Verfasst von Haiwei Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China; National Research Center of Engine…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Foot-and-Mouth Disease Virus, Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Jiangsu Agricultural Science and Technology Innovation Fund, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the most potent professional antigen presenting cells, dendritic cells (DCs) have been targeted in strategies to enhance vaccination efficacy. To date, targeted delivery has been mainly used for cancer therapy, with few studies focusing on vaccine antigens for animal epidemic diseases. In this study, we selected a series of mouse DC-specific nanobodies from a non-immunized camel. The four candidate nanobodies identified (Nb4, Nb13, Nb17, and Nb25), which showed efficient endocytosis of bone marrow-derived DCs, were evaluated as potential vaccine antigen targeted delivery vehicles. First, green fluorescent protein (GFP) was selected and four corresponding DCNb-GFP fusions were constructed for verification. Nb17-GFP was effective at promoting antibody production, inducing a cellular immune response, and increasing the IL-4 level. Second, foot-and-mouth disease virus (FMDV) and a FMDV-specific nanobody (Nb205) were selected and four bispecific nanobody DCNb-Nb205 fusions were generated to investigate the feasibility of a novel targeting antigen delivery vehicle. The resulting bispecific nanobody, Nb17-Nb205, could not only deliver FMDV particles instead of antigenic peptide, but also induced the production of specific antibodies, a cellular immune response, and IFN-γ and IL-4 levels upon immunization with a single subcutaneous injection. In conclusion, our results demonstrate the potential of bispecific nanobody as a novel and efficient DC-specific antigen delivery vehicle. This highlights the potential to expand targeted delivery to the field of animal epidemic diseases and provides a reference for the general application of nanotechnology in viral diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesFoot-and-Mouth Disease VirusVaccinesMiceAnimalsInterleukin-4PeptidesDendritic Cells

Stichwörter der Autor:innen

Bispecific nanobodyDendritic cellEndocytosisTargeted deliveryVaccine

Substanzen

Single-Domain AntibodiesInterleukin-4PeptidesVaccines

Autor:innen und Institutionen

  • Institute of Veterinary Immunology & Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China; National Research Center of Engineering and Technology for Veterinary Biologicals, Jiangsu Academy of Ag…
  • Nanjing Agricultural University, Nanjing 210095, China.

Förderung

  • Jiangsu Agricultural Science and Technology Innovation Fund
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Jiangsu Provincial Key Research and Development Program
  • Jiangsu Academy of Agricultural Sciences

Zitieren

APA

Cheng, H., Yang, L., Hou, L., Cai, Z., Yu, X., Du, L., Chen, J., & Zheng, Q. (2023). Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2023.110140

Vancouver

Cheng H, Yang L, Hou L, Cai Z, Yu X, Du L, et al. Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody. International Immunopharmacology. 2023. doi:10.1016/j.intimp.2023.110140

BibTeX
@article{Cheng2023,
  author = {Cheng, Haiwei and Yang, Li and Hou, Liting and Cai, Zizheng and Yu, Xiaoming and Du, Luping and Chen, Jin and Zheng, Qisheng},
  title = {Promoting immunity with novel targeting antigen delivery vehicle based on bispecific nanobody},
  journal = {International Immunopharmacology},
  year = {2023},
  doi = {10.1016/j.intimp.2023.110140}
}
Kostenlos starten →